Asia Pacific Intravascular Ultrasound (IVUS) Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Modality (Virtual Histology IVUS, iMap IVUS, and Integrated Backscatter IVUS), Product (Equipment, and Accessories [Catheters, Guidewir

Asia Pacific Intravascular Ultrasound (IVUS) Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Modality (Virtual Histology IVUS, iMap IVUS, and Integrated Backscatter IVUS), Product (Equipment, and Accessories [Catheters, Guidewires, and Others]), and End User (Hospitals and Clinics, Diagnostic Centers, and Academic and Research Institutes)

The Asia Pacific intravascular ultrasound devices market is expected to reach US$ 237.06 million by 2028 from US$ 138.26 million in 2021; it is estimated to grow at a CAGR of 8.0% from 2021 to 2028.

The market growth is ascribed to the rising prevalence of coronary disorders and increasing R&D activities along with improving healthcare infrastructure. However, recalls of IVUS restrict the market growth.

Leading market players increase their penetration across emerging markets by expanding their distribution networks and augmented manufacturing capabilities. Emerging markets in South Korea and India are expected to offer potential growth opportunities for the companies offering crucial intravascular ultrasound devices. This can be correlated to the large patient population, high CVD prevalence, increasing disposable incomes, improving healthcare infrastructure, and growing medical tourism in these countries.

Asia Pacific has become a business-friendly and resilient hub due to relatively less stringent regulations and data requirements. As the US and European markets mature, most players are relocating their focus to emerging markets. Increasing investments by market players in emerging countries play a crucial role in the upgrading of technologies in these countries. For instance, in December 2021, Conavi Medical Inc. entered into funding agreements worth US$ 20 million to support the commercialization of its innovative intravascular image guidance technology. Therefore, the rising potential of emerging economies supports the inclination toward CVDs diagnosis.

Various economies worldwide, such as Japan, China, India, and South Korea, are considerably modernizing their healthcare facilities and services. As a result, the life expectancy of people in these countries has increased, leading to the growth in their geriatric population base. Age is a prominent risk factor in the development of CVDs. Heart’s physiological aging, and increased oxidative stress and inflammation are the major factors causing the onset and manifestation of CVDs. Thus, a rise in the elderly population underlines the demand for intravascular ultrasound devices (IVUS).

The interruptions in supply chains and the massive demand for efficient treatments for the treatment of COVID-19 have put the healthcare research industry in Asia Pacific in a crucial position. Prohibited measures have been taken to contain the spread of SARS-Co V-2. Cancer screening, diagnosis, and treatment were either postponed or delayed prioritizing the COVID patients in 2020, which hampered the demand for intravascular ultrasound (IVUS) devices. In addition, inflation, negative GDP, and unemployment struck many countries in the region. The pandemic has affected three main aspects of the global economy: manufacturing, supply chain, and business and financial markets. Medical device manufacturers and suppliers are shifting their focus to developing and supplying COVID-19 essentials and medical devices for respiratory diseases. Patients suffering from hypertension, diabetes, cardiovascular conditions, etc., are more susceptible to the novel coronavirus than individuals who are not suffering from any major health conditions. Researchers are increasingly investing time and resources toward understanding the role of point-of-care ultrasound amid the ongoing pandemic, particularly for dialytic patients. While research and development activities are likely to pick up the pace in the coming years, medical device market players are expected to address issues that hampered supply chains amid stringent trade and transportation restrictions.

Asia Pacific Intravascular Ultrasound (IVUS) Devices Market Revenue and Forecast to 2028 (US$ Mn)

ASIA PACIFIC INTRAVASCULAR ULTRASOUND (IVUS) DEVICES MARKET SEGMENTATION

By Modality

Virtual Histology IVUS i Map IVUS Integrated Backscatter IVUSBy Product

Equipment Accessories Catheters Guidewires Others By End User

Hospitals and Clinics Diagnostic Centers Others By Country

China Japan India Australia South Korea Rest of Asia Pacific Company Profiles

Koninklijke Philips N.V GE Healthcare Siemens AG Boston Scientific Corporation Infraredx, Inc. Terumo Corporation Conavi Medical Inc. Canon Medical Systems Abbott

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific intravascular ultrasound devices market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific intravascular ultrasound devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.